drugset
drugset / Trial / NCT05113615

Regular Use Tiotropium and Tolerance to Bronchoprotection in Mild Asthma

NCT05113615 ↗

Phase 4 Completed 12 enrolled University of Saskatchewan
RandomizedCrossoverTriple-blindTreatment

Summary

The study will assess if regular use of tiotropium (i.e. daily) results in loss of bronchoprotection against methacholine induced bronchoconstriction in those with mild asthma.

Timeline

Start
2021-12-13
Primary completion
2022-05-06
Completion
2022-05-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tiotropium Other / unclassified 5 ug Inhaled

Indications

asthma